Adrenomedullin production is increased in normal human pregnancy

Laboratory of Perinatal Medicine and Molecular Biology, University La Sapienza, Rome, Italy.

OBJECTIVE: Adrenomedullin, a recently discovered vasoactive peptide originally identified in pheochromocytoma, has been found to be increased in the plasma of pregnant women at term. This study was designed to elucidate whether adrenomedullin secretion is dependent on gestational age and the possible source and function of this peptide in human pregnancy. STUDY DESIGN: Adrenomedullin concentrations were determined by RIA in amniotic fluid and maternal plasma obtained from 110 pregnant women between 8 and 40 weeks of gestation. Subjects were stratified into five groups according to gestational age. In term patients (n = 15), adrenomedullin was also measured in the umbilical artery and vein separately. RESULTS: High concentrations of adrenomedullin were present in plasma and amniotic fluid samples from patients in the first, second and third trimester. There was no significant difference in mean maternal plasma concentration of adrenomedullin between the five patient groupings. Amniotic fluid adrenomedullin concentrations decreased from 81.2 +/- 11.7 pg/ml at 8-12 weeks of gestation to 63.7 +/- 6.0 pg/ml at 13-20 weeks of gestation and then increased at 21-28 weeks of gestation to 99.1 +/- 10.4 pg/ml. A further increase was found in samples collected after 37 weeks of gestation (132.6 +/- 10.1 pg/ml). In the umbilical vein, adrenomedullin concentration was higher (P < 0.05) than in the artery (65.7 +/- 6.1 pg/ml and 48.5 +/- 5.2 pg/ml respectively), suggesting that adrenomedullin in the fetal circulation derives from the placenta. CONCLUSIONS: Our results demonstrate the presence of adrenomedullin in maternal plasma and amniotic fluid throughout gestation, and show that its production starts very early in gestation, suggesting that this hormone may have an important role in human reproduction, from implantation to delivery.

This article has been cited by other articles:

				M. Li, Y. Wu, and K. M. Caron Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice Biol Reprod, December 1, 2008; 79(6): 1169 - 1175. [Abstract] [Full Text] [PDF]

				H.W.F. van Eijndhoven, R. Aardenburg, M.E.A. Spaanderman, J.G.R. De Mey, and L.L.H. Peeters Pregnancy Enhances the Prejunctional Vasodilator Response to Adrenomedullin in Selective Regions of the Arterial Bed of Wistar Rats Reproductive Sciences, December 1, 2007; 14(8): 771 - 779. [Abstract] [PDF]

				M. Chauhan, G. R. Ross, U. Yallampalli, and C. Yallampalli Adrenomedullin-2, a Novel Calcitonin/Calcitonin-Gene-Related Peptide Family Peptide, Relaxes Rat Mesenteric Artery: Influence of Pregnancy Endocrinology, April 1, 2007; 148(4): 1727 - 1735. [Abstract] [Full Text] [PDF]

				E. Marinoni, C. Zacharopoulou, A. Di Rocco, C. Letizia, M. Moscarini, and R. Di Iorio Effect of Betamethasone In Vivo on Placental Adrenomedullin in Human Pregnancy Reproductive Sciences, September 1, 2006; 13(6): 418 - 424. [Abstract] [PDF]

				A. Al-Ghafra, N.M. Gude, S.P. Brennecke, and R.G. King Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia Mol. Hum. Reprod., March 1, 2006; 12(3): 181 - 186. [Abstract] [Full Text] [PDF]

				H Watanabe, E Takahashi, M Kobayashi, M Goto, A Krust, P Chambon, and T Iguchi The estrogen-responsive adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor J. Mol. Endocrinol., February 1, 2006; 36(1): 81 - 89. [Abstract] [Full Text] [PDF]

				J. Penchalaneni, S. J. Wimalawansa, and C. Yallampalli Adrenomedullin Antagonist Treatment During Early Gestation in Rats Causes Fetoplacental Growth Restriction Through Apoptosis Biol Reprod, November 1, 2004; 71(5): 1475 - 1483. [Abstract] [Full Text] [PDF]

				R. J. Gratton, M. Gluszynski, D. M. Mazzuca, K. Nygard, and V. K. M. Han Adrenomedullin Messenger Ribonucleic Acid Expression in the Placentae of Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6048 - 6055. [Abstract] [Full Text] [PDF]

				H. Li, J. Dakour, S. Kaufman, L. J. Guilbert, B. Winkler-Lowen, and D. W. Morrish Adrenomedullin Is Decreased in Preeclampsia Because of Failed Response to Epidermal Growth Factor and Impaired Syncytialization Hypertension, November 1, 2003; 42(5): 895 - 900. [Abstract] [Full Text] [PDF]

				T. Moriyama, T. Otani, and T. Maruo Expression of Adrenomedullin by Human Placental Cytotrophoblasts and Choriocarcinoma JAr Cells J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3958 - 3961. [Abstract] [Full Text] [PDF]

				S. Jerat, D. W. Morrish, S. T. Davidge, and S. Kaufman Effect of Adrenomedullin on Placental Arteries in Normal and Preeclamptic Pregnancies Hypertension, February 1, 2001; 37(2): 227 - 231. [Abstract] [Full Text] [PDF]